Neurotensin
EmergingNeurotensin is elevated in certain GI neuroendocrine tumors; its receptor is an emerging target for radioligand cancer therapy.
Neurotensin is a gut/brain hormone that's elevated in some rare digestive tumors. Researchers are also exploring whether its receptor could be used to specifically target certain cancers with radioactive treatment, similar to approaches already used for other neuroendocrine tumors.
Neurotensin is a gut/brain peptide hormone involved in digestive regulation and neurotransmission, with growing research relevance to certain neuroendocrine tumors.
Elevated levels are seen in certain gastrointestinal neuroendocrine tumors; neurotensin receptor expression is also being explored as a potential target for tumor-directed therapy in select cancers.
Not a standardized diagnostic blood test in routine practice; measured primarily in research settings or specialized neuroendocrine tumor centers.
Neurotensin receptor signaling is an active area of cancer research, including neurotensin-receptor-targeted radioligand therapy in early clinical trials for pancreatic cancer, following a similar model to other peptide-receptor radionuclide therapies used in neuroendocrine oncology.
Not yet a standardized diagnostic test; primarily relevant in specialized neuroendocrine tumor research and early clinical trials.
- General oncology reference literature on neurotensin receptor-targeted therapy research in neuroendocrine and pancreatic tumors.